Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) shot up 3.4% during trading on Wednesday . The company traded as high as $13.25 and last traded at $13.22, with a volume of 1,478,016 shares trading hands. The stock had previously closed at $12.78.

A number of research firms recently commented on MDRX. Deutsche Bank AG reissued a “buy” rating on shares of Allscripts Healthcare Solutions in a research report on Sunday, April 17th. Robert W. Baird reaffirmed a “buy” rating on shares of Allscripts Healthcare Solutions in a report on Sunday, May 8th. Zacks Investment Research cut shares of Allscripts Healthcare Solutions from a “buy” rating to a “sell” rating in a report on Wednesday, April 20th. Canaccord Genuity reaffirmed a “buy” rating and issued a $18.00 price target on shares of Allscripts Healthcare Solutions in a report on Thursday, March 24th. Finally, KeyCorp reaffirmed a “hold” rating on shares of Allscripts Healthcare Solutions in a report on Sunday, May 22nd. Eleven equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $15.86.

The company has a market cap of $2.51 billion and a price-to-earnings ratio of 253.02. The stock’s 50-day moving average is $12.93 and its 200-day moving average is $13.31.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Thursday, May 5th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of $0.12 by $0.01. The business earned $346 million during the quarter, compared to analysts’ expectations of $348.51 million. During the same quarter last year, the company earned $0.08 EPS. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. On average, analysts predict that Allscripts Healthcare Solutions Inc. will post $0.58 EPS for the current year.

In related news, President Richard J. Poulton sold 10,000 shares of the company’s stock in a transaction on Monday, June 13th. The shares were sold at an average price of $13.03, for a total value of $130,300.00. Following the completion of the sale, the president now owns 343,813 shares in the company, valued at approximately $4,479,883.39. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Paul Black sold 15,000 shares of the company’s stock in a transaction on Monday, June 13th. The shares were sold at an average price of $13.04, for a total transaction of $195,600.00. Following the completion of the sale, the chief executive officer now owns 1,197,329 shares of the company’s stock, valued at approximately $15,613,170.16. The disclosure for this sale can be found here.

A number of institutional investors have recently made changes to their positions in the company. Neuberger Berman Group LLC increased its position in shares of Allscripts Healthcare Solutions by 1.2% in the fourth quarter. Neuberger Berman Group LLC now owns 2,392,804 shares of the company’s stock worth $36,801,000 after buying an additional 27,541 shares during the last quarter. Tamarack Advisers LP purchased a new position in shares of Allscripts Healthcare Solutions during the fourth quarter worth approximately $28,453,000. Cornerstone Capital Management Holdings LLC. increased its position in shares of Allscripts Healthcare Solutions by 24.1% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 994,225 shares of the company’s stock worth $15,291,000 after buying an additional 193,111 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Allscripts Healthcare Solutions by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 608,152 shares of the company’s stock worth $9,353,000 after buying an additional 14,595 shares during the last quarter. Finally, Russell Frank Co increased its position in shares of Allscripts Healthcare Solutions by 48.4% in the fourth quarter. Russell Frank Co now owns 603,169 shares of the company’s stock worth $9,300,000 after buying an additional 196,775 shares during the last quarter.

Allscripts Healthcare Solutions, Inc delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.